Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

The impact of statin therapy and aerobic exercise training on skeletal muscle and whole-body aerobic capacity [with consumer summary]
Slade JM, Abela GS, Rozman M, McClowry RJ, Hurley D, Forbes SC, Meyer RA
American Heart Journal Plus: Cardiology Research and Practice 2021 May;5:100028
clinical trial
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Statin use is widely recognized for improving cardiovascular health, but questions remain on how statin use influences skeletal muscle, particularly mitochondrial function. STUDY OBJECTIVE DESIGN AND PARTICIPANTS: The influence of statin therapy and exercise (EX) on aerobic capacity was determined. In Study 1, skeletal muscle aerobic capacity was measured before and after 80 mg atorvastatin therapy. In Study 2, aerobic capacity (skeletal muscle and whole body) was measured before and after a 12-week exercise randomized control trial in older adults (age 67 +/- 5 yrs.), a subset of which were on chronic low-moderate intensity statin therapy. MAIN OUTCOME MEASURES: Muscle oxidative capacity was determined from the phosphocreatine recovery rate constant (kPCr) using 31P Magnetic Resonance Spectroscopy. Whole body peak oxygen uptake (VO2 peak) was measured during a graded exercise test with indirect calorimetry. RESULTS: High dose statin therapy resulted in a 12% reduction in muscle oxidative capacity (pre = 1.34 +/- 0.34 min, post = 1.17 +/- 0.25 min, p = 0.004). Similarly, chronic low-moderate dose statin therapy was associated with lower muscle oxidative capacity at baseline (1.50 +/- 0.35 min) compared to non-statin users (1.88 +/- 0.047 min, p = 0.019). Following EX, muscle oxidative capacity increased by 35 to 40% (statin: Pre: 1.39 +/- 0.44 versus Post: 1.88 +/- 0.47 min, no statin Pre: 1.86 +/- 0.58 versus Post: 2.58 +/- 0.85 min) compared to control groups (Pre: 1.74 +/- 0.27 versus Post: 1.75 +/- 0.49 min, p = 0.001). VO2 peak increased by 11% for EX groups (Pre: 18.8 +/- 2.8 versus Post: 20.8 +/- 3.0 ml/kg/min) following training compared to a small decline in controls (Pre: 21.8 +/- 3.7 versus Post: 20.8 +/- 3.04 ml/kg/min, p = 0.001). CONCLUSIONS: Statin therapy resulted in reduced muscle oxidative capacity. Aerobic exercise improved skeletal muscle oxidative capacity and whole-body aerobic capacity during statin therapy.

Full text (sometimes free) may be available at these link(s):      help